Back
Soligenix Vs. Edgewise Therapeutics Industry Stock Comparison
Sell
31
SNGX
Soligenix
Last Price:
3.81
Seasonality Move:
-12.52%
Buy
53
EWTX
Edgewise Therapeutics
Last Price:
29.51
Seasonality Move:
-4.53%
Sell
31
Soligenix (SNGX)
is a Sell
Is Soligenix a Buy, Sell or Hold?
- The current Soligenix [SNGX] share price is $4.01. The Score for SNGX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- SNGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $19.07. The Score for EWTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SNGX Stock Price Chart
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $19.07
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing slight selling pressure.
SNGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 53.37 | Buy |
| Chaikin Money Flow: | 31839 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.37 - 4.27) | Buy |
| Bollinger Bands (100): | (3.18 - 6.08) | Sell |
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 54.68 | Buy |
| Chaikin Money Flow: | -217791 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.41 - 19.53) | Buy |
| Bollinger Bands (100): | (16.73 - 20.17) | Buy |
SNGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.6 | Buy |
| 20-day SMA: | 3.77 | Buy |
| 50-day SMA: | 4.4 | Sell |
| 200-day SMA: | 7.49 | Sell |
| 8-day EMA: | 3.69 | Buy |
| 20-day EMA: | 3.75 | Buy |
| 50-day EMA: | 4.1 | Sell |
| 200-day EMA: | 9.22 | Sell |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.77 | Buy |
| 20-day SMA: | 18.44 | Buy |
| 50-day SMA: | 18.78 | Buy |
| 200-day SMA: | 16.45 | Buy |
| 8-day EMA: | 18.05 | Buy |
| 20-day EMA: | 18.12 | Buy |
| 50-day EMA: | 18.3 | Buy |
| 200-day EMA: | 16.21 | Buy |
Soligenix Earnings Growth & SNGX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.00 per share, and an increase next year of $0.35 per share.
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.09 per share, an increase this year of $0.05 per share, and a decrease next year of $0.36 per share.
Soligenix Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Edgewise Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||